000 01630 a2200457 4500
005 20250516155532.0
264 0 _c20140225
008 201402s 0 0 eng d
022 _a2041-4889
024 7 _a10.1038/cddis.2013.219
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBarathan, M
245 0 0 _aHypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases.
_h[electronic resource]
260 _bCell death & disease
_cJun 2013
300 _ae697 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnthracenes
650 0 4 _aApoptosis
650 0 4 _aBH3 Interacting Domain Death Agonist Protein
_xgenetics
650 0 4 _aCaspases
_xgenetics
650 0 4 _aCell Shape
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDNA Fragmentation
650 0 4 _aGene Expression
_xdrug effects
650 0 4 _aHep G2 Cells
650 0 4 _aHumans
650 0 4 _aInflammation Mediators
_xmetabolism
650 0 4 _aInterleukin-6
_xmetabolism
650 0 4 _aPerylene
_xanalogs & derivatives
650 0 4 _aPhotochemotherapy
650 0 4 _aPhotosensitizing Agents
_xpharmacology
650 0 4 _aReactive Oxygen Species
_xmetabolism
650 0 4 _aUp-Regulation
700 1 _aMariappan, V
700 1 _aShankar, E M
700 1 _aAbdullah, B J J
700 1 _aGoh, K L
700 1 _aVadivelu, J
773 0 _tCell death & disease
_gvol. 4
_gp. e697
856 4 0 _uhttps://doi.org/10.1038/cddis.2013.219
_zAvailable from publisher's website
999 _c22872833
_d22872833